Change of Tide in Reform: Lopsided Cost Cuts to Balanced Pro-Innovation Policy

December 27, 2023
Japan has largely finalized the drug pricing reform package for FY2024. While some details remain to be adjusted, it is now clear that the reform plan embraces a lot of measures corresponding to requests made by the pharmaceutical industry. The...read more